Xavier Thomas

571 total citations · 1 hit paper
7 papers, 430 citations indexed

About

Xavier Thomas is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Xavier Thomas has authored 7 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Xavier Thomas's work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neutropenia and Cancer Infections (2 papers). Xavier Thomas is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neutropenia and Cancer Infections (2 papers). Xavier Thomas collaborates with scholars based in France, United States and Canada. Xavier Thomas's co-authors include Claude Preudhomme, Christian Récher, Céline Berthon, Karen Yee, Bruno Quesnel, Carmen Kahatt, Carlos Gomez‐Roca, François Lokiec, Emmanuel Raffoux and Keyvan Rezaï and has published in prestigious journals such as American Journal of Hematology, European Journal Of Haematology and Annals of Hematology.

In The Last Decade

Xavier Thomas

7 papers receiving 422 citations

Hit Papers

Bromodomain inhibitor OTX015 in patients with acute leuka... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Thomas France 6 333 259 77 74 29 7 430
Alessandra Scardocci Italy 8 324 1.0× 165 0.6× 103 1.3× 67 0.9× 42 1.4× 9 402
Kathrin M. Bernt United States 3 575 1.7× 315 1.2× 72 0.9× 37 0.5× 27 0.9× 3 652
Jolien De Bie Belgium 6 174 0.5× 111 0.4× 92 1.2× 52 0.7× 18 0.6× 12 273
Eddy H.J. Van Roon Netherlands 7 174 0.5× 130 0.5× 172 2.2× 41 0.6× 22 0.8× 7 283
Guillermo Garcia-Manero United States 5 90 0.3× 97 0.4× 93 1.2× 44 0.6× 23 0.8× 14 216
Marta Libura Poland 6 105 0.3× 136 0.5× 81 1.1× 24 0.3× 32 1.1× 11 212
Christina Schessl Germany 5 194 0.6× 162 0.6× 35 0.5× 26 0.4× 51 1.8× 6 275
Samuel Gusscott Canada 8 210 0.6× 92 0.4× 122 1.6× 62 0.8× 27 0.9× 16 345
Michael T. Zimmerman United States 2 89 0.3× 250 1.0× 129 1.7× 32 0.4× 55 1.9× 2 282
Michaël Broux Belgium 6 128 0.4× 114 0.4× 125 1.6× 55 0.7× 30 1.0× 6 277

Countries citing papers authored by Xavier Thomas

Since Specialization
Citations

This map shows the geographic impact of Xavier Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Thomas more than expected).

Fields of papers citing papers by Xavier Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Thomas. The network helps show where Xavier Thomas may publish in the future.

Co-authorship network of co-authors of Xavier Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Thomas. A scholar is included among the top collaborators of Xavier Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Thomas. Xavier Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lambert, Juliette, Jérôme Lambert, Xavier Thomas, et al.. (2021). Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML. Blood Advances. 5(23). 5258–5268. 17 indexed citations
2.
Thomas, Xavier, Gaëlle Fossard, Mohamed Elhamri, et al.. (2020). LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020020–e2020020. 2 indexed citations
3.
Ducastelle-Leprêtre, Sophie, Hélène Labussière‐Wallet, Franck E. Nicolini, et al.. (2016). Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?. Annals of Hematology. 96(3). 363–371. 7 indexed citations
4.
Berthon, Céline, Emmanuel Raffoux, Xavier Thomas, et al.. (2016). Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. The Lancet Haematology. 3(4). e186–e195. 336 indexed citations breakdown →
5.
Heiblig, Maël, Mohamed Elhamri, Alexandre Deloire, et al.. (2016). Acute myeloid leukemia in the elderly (age 70 yr or older): long‐term survivors. European Journal Of Haematology. 98(2). 134–141. 5 indexed citations
6.
Dombret, Hervé, Xavier Thomas, Patrice Chevallier, et al.. (2016). Healthcare burden and reimbursement of hospitalization during chemotherapy for adults with Ph-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in France: a retrospective chart review. Journal of Medical Economics. 19(11). 1034–1039. 6 indexed citations
7.
Thomas, Xavier, et al.. (2001). Acute lymphoblastic leukemia in the elderly: The Edouard Herriot hospital experience. American Journal of Hematology. 67(2). 73–83. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026